Chronic vagal nerve stimulation has no effect on tachycardia‐induced heart failure progression or excitation–contraction coupling

Autor: Graeme Kirkwood, David A. Eisner, Michael Lawless, Emma J. Radcliffe, Charles M. Pearman, Amy Watkins, Andrew W. Trafford, Sophie N Saxton
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Cardiovascular Conditions
Disorders and Treatments

Tachycardia
medicine.medical_specialty
Vagus Nerve Stimulation
Physiology
Vagal nerve
chemistry.chemical_element
heart failure
Stimulation
030204 cardiovascular system & hematology
Calcium
Autonomic Nervous System
vagal nerve stimulation
lcsh:Physiology
03 medical and health sciences
0302 clinical medicine
Tachycardia-induced cardiomyopathy
Physiology (medical)
Internal medicine
medicine
Animals
Autonomic dysregulation
Myocytes
Cardiac

Calcium Signaling
Vagal tone
Cells
Cultured

Excitation Contraction Coupling
Original Research
Sheep
calcium
lcsh:QP1-981
business.industry
Heart
medicine.disease
tachycardia‐induced cardiomyopathy
chemistry
Heart failure
Cardiology
Female
medicine.symptom
business
030217 neurology & neurosurgery
parasympathetic
Zdroj: Physiological Reports, Vol 8, Iss 2, Pp n/a-n/a (2020)
Physiological Reports
Radcliffe, E, Pearman, C, Watkins, A, Lawless, M, Kirkwood, G, Saxton, S, Eisner, D & Trafford, A 2020, ' Chronic vagal nerve stimulation has no effect on tachycardia-induced heart failure progression or excitation-contraction coupling ', Physiological Reports, vol. 8, no. 2, e14321 . https://doi.org/10.14814/phy2.14321
DOI: 10.14814/phy2.14321
Popis: Autonomic dysregulation plays a key role in the development and progression of heart failure (HF). Vagal nerve stimulation (VNS) may be a promising therapeutic approach. However, the outcomes from clinical trials evaluating VNS in HF have been mixed, and the mechanisms underlying this treatment remain poorly understood. Intermittent high‐frequency VNS (pulse width 300 µs, 30 Hz stimulation, 30 s on, and 300 s off) was used in healthy sheep and sheep in which established HF had been induced by 4 weeks rapid ventricular pacing to assess (a) the effects of VNS on intrinsic cardiac vagal tone, (b) whether VNS delays the progression of established HF, and (c) whether high‐frequency VNS affects the regulation of cardiomyocyte calcium handling in health and disease. VNS had no effect on resting heart rate or intrinsic vagal tone in the healthy heart. Although fewer VNS‐treated animals showed subjective signs of heart failure at 6 weeks, overall VNS did not slow the progression of clinical or echocardiographic signs of HF. Chronic VNS did not affect left ventricular cardiomyocyte calcium handling in healthy sheep. Rapid ventricular pacing decreased the L‐type calcium current and calcium transient amplitude, but chronic VNS did not rescue dysfunctional calcium handling. Overall, high‐frequency VNS did not prevent progression of established HF or influence cellular excitation–contraction coupling. However, a different model of HF or selection of different stimulation parameters may have yielded different results. These results highlight the need for greater insight into VNS dosing and parameter selection and a deeper understanding of its physiological effects.
The effects of chronic vagal nerve stimulation (VNS) on cardiac function and calcium cycling were assessed in healthy sheep and sheep in which heart failure had been induced by rapid pacing. VNS did not affect calcium cycling in health or disease states and did not improve echocardiographic or biochemical markers of heart failure.
Databáze: OpenAIRE